MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 158 filers reported holding MERSANA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,650,584 | +49.0% | 368,434 | +9.4% | 0.01% | 0.0% |
| Q2 2023 | $1,107,598 | -44.5% | 336,656 | -30.7% | 0.01% | -57.1% |
| Q1 2023 | $1,996,260 | -18.3% | 485,708 | +16.5% | 0.01% | -30.0% |
| Q4 2022 | $2,442,823 | +69.1% | 416,864 | +95.0% | 0.02% | +33.3% |
| Q3 2022 | $1,445,000 | -16.7% | 213,763 | -23.3% | 0.02% | +66.7% |
| Q4 2021 | $1,734,000 | +13.5% | 278,798 | +72.1% | 0.01% | -10.0% |
| Q3 2021 | $1,528,000 | -4.2% | 162,036 | +37.9% | 0.01% | 0.0% |
| Q2 2021 | $1,595,000 | -46.7% | 117,478 | -36.5% | 0.01% | -50.0% |
| Q1 2021 | $2,995,000 | +262.2% | 185,108 | +495.6% | 0.02% | +150.0% |
| Q4 2020 | $827,000 | -42.6% | 31,080 | -59.9% | 0.01% | -52.9% |
| Q3 2020 | $1,442,000 | +426.3% | 77,445 | +561.8% | 0.02% | +325.0% |
| Q2 2020 | $274,000 | – | 11,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 818,033 | $14,144,000 | 22.27% |
| ProQuest Associates IV LLC | 955,709 | $16,524,000 | 16.55% |
| NEA Management Company, LLC | 8,144,267 | $140,814,000 | 4.93% |
| Rock Springs Capital Management LP | 1,330,000 | $22,996,000 | 1.06% |
| Cormorant Asset Management, LP | 295,549 | $5,110,000 | 0.90% |
| ArrowMark Colorado Holdings LLC | 477,711 | $8,260,000 | 0.09% |
| Spark Investment Management LLC | 18,688 | $323,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,391,404 | $41,348,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 20,000 | $346,000 | 0.01% |
| Laurion Capital Management LP | 50,000 | $865,000 | 0.00% |